Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment !

Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.

Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment ! English

Overview

Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.

This Activity for

  • Resident / Fellow
  • Physician

What I will learn?

Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.

Additional items to the activity

Optional Details Type Fee
Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment ! Certificate

Certificate

Certificate Free
VAT 15% Included

About Organizer

Contact the organizer and they will be glad to help!

Virtual Medical Academy

was 0 SAR

Free
0%coupon Discount
  • calendar 22 Nov 2023
  • clock 03:30 pm - 04:30 pm - Saudi Arabia (+03:00)
  • quality Certificate Available
  • adjust no access Materiel
  • Registration Policy Full Course
  • Completion Role You must attend all the Sessions
  • Refund Policy No Refund
Free